A Study in Patients With Trichotillomania
Public ClinicalTrials.gov record NCT03797521. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double Blind, Placebo-Controlled Study to Explore the Safety, Tolerability, and Activity of SXC-2023 in Adults With Moderate to Severe Trichotillomania (TTM) When Dosed for 6 Weeks
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to explore the safety, tolerability and activity of SXC-2023 when dosed for 6 weeks versus placebo in adult patients with moderate to severe Trichotillomania.
Study identification
- NCT ID
- NCT03797521
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 128 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 18, 2018
- Primary completion
- Dec 1, 2019
- Completion
- Dec 15, 2019
- Last update posted
- Oct 27, 2021
2018 – 2019
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CNRI- Los Angeles | Pico Rivera | California | 90662 | — |
| Artemis Institute for Clinical Research | Riverside | California | 92503 | — |
| Behavioral Clinical Research | North Miami | Florida | 33161 | — |
| iResearch Atlanta | Decatur | Georgia | 30030 | — |
| Univ of Chicago | Chicago | Illinois | 60637 | — |
| Lake Charles Clinical Trials | Lake Charles | Louisiana | 70629 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Integrative Clinical Trials, LLC | Brooklyn | New York | 11229 | — |
| Finger Lakes Clinical Research | Rochester | New York | 14618 | — |
| Insight Clinical Trials, LLC | Shaker Heights | Ohio | 44122 | — |
| IPS Research Company | Oklahoma City | Oklahoma | 73103 | — |
| Carolina Clinical Trials, Inc | Charleston | South Carolina | 29407 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Trichotillomania trials
Other public records listing Trichotillomania. Sorted by last update posted; newest first. Not a recommendation.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03797521, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 27, 2021 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03797521 live on ClinicalTrials.gov.